Delivery Order SPE2DB24D2012-SPE2DB25FBWWE
Award Date 9/3/25
Potential Completion Date 9/4/25
Potential Value $12K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 360 mg Deferasirox tablets (30-count units) on May 16, 2025, with a ceiling value of $5,673.37 and an ultimate completion date of May 19, 2025. This is a firm fixed-price delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The award represents a competitive, non-set-aside...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 25, 2025, for Deferasirox 360 mg tablets in quantities of 30 tablets. This firm fixed price delivery order, valued at $9,492.73, was competitively awarded without a set-aside designation and carries an ultimate completion date of August 26, 2025. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,991.52 to AmerisourceBergen Drug Corp for Deferasirox 500 mg tablets for suspension (30-count units) on September 24, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award, and is scheduled for completion by September 25, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Deferasirox 360 mg tablets (30-count packages) under a firm fixed-price contract type. The award, valued at approximately $24.9K, was competitively awarded without set-aside designation and carries an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from...
- The Defense Logistics Agency awarded a delivery order valued at $47,526.27 to AmerisourceBergen Drug Corp for the supply of Deferasirox 360 mg tablets (30-count units). This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by September 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEFERASIROX 180 MG GRANULE PKT 30S, with a ceiling value of $1,728.00 and a performance period through May 15, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide DEFERASIROX 360 MG TABLET 30S. The firm fixed price contract has a potential value of $13,105.98 and a performance completion date of December 29, 2023. No set-aside designation was used. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to supply pharmaceuticals, medical...
- AmerSourceBergen Drug Corp was awarded a $20,687.26 firm fixed-price delivery order (Contract No. 4568983092) by the Defense Logistics Agency's Medical Supply Chain division on August 4, 2025. The delivery order, with an ultimate completion date of August 4, 2025, represents a child award under the company's broader indefinite delivery contract vehicle. The award was competitively procured with no set-aside designation, and performance will be executed at the contractor's Corporate Office...
- AmerSourceBergen Drug Corp was awarded a delivery order valued at $9,087.12 by the Defense Logistics Agency's Medical Supply Chain on September 12, 2025, with an ultimate completion date of September 15, 2025. This firm fixed-price, competitively awarded contract (no set-aside utilized) is a child order under AmerSourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at the...
- AmerSourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency's Medical Supply Chain on September 4, 2025, with an ultimate completion date of September 5, 2025. This firm fixed-price delivery order, valued at $3,461.10, represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The award was made through open competition...